America Doesn’t Have a Marijuana Problem, It Has a Cannabis Education Gap
The cannabis education gap is a critical issue slowing clinical program development and physician training. Without proper cannabis education, patients lack access to safe, guided care. Addressing this gap is essential for advancing clinical cannabis use.
So, What Does an Adult at Low Risk of Cannabis Dependence Look Like?
Understanding cannabis adult low risk dependence is essential for safe therapeutic use. Identifying risk factors helps patients and physicians create individualized treatment plans. This knowledge supports safer cannabis use with minimized dependence…
Teen Cannabis Use Linked to Serious Mental Illness Risks
Adolescent cannabis use psychotic disorders risk is a growing concern supported by emerging research. Teens using cannabis during brain development face increased chances of serious psychiatric conditions. Understanding these risks helps guide harm…
Indiana S.B. 250 Threatens Hemp-Derived Cannabinoid Beverage Sales
Indiana's S.B. 250 could severely impact hemp-derived cannabinoid beverage sales, risking patient access to these regulated products. This legislation threatens to push consumers toward unregulated markets with safety concerns. Understanding the…
Boulder and CBD: Understanding Full-Spectrum Benefits
Full-spectrum CBD benefits are key to understanding the entourage effect in cannabis medicine. Patients often experience better relief with full-spectrum formulations than with CBD isolate alone. This synergy of cannabinoids and terpenes offers enhanced…
More Kentucky Children Dying to ‘Preventable’ Overdoses, New Report Shows
Pediatric cannabinoid ingestions are an urgent safety concern in cannabis-using households. Secure, locked storage and childproof packaging are essential to prevent accidental overdoses. This report highlights the need for better prevention to protect…
Researcher: Remediated Cannabis May Still Contain Harmful Mold
Remediated cannabis mold contamination remains a significant concern despite passing state lab tests. Current testing protocols may not detect all harmful mold species in cannabis products. This issue is critical for immunocompromised patients and those…
New Study Links Adolescent Cannabis Exposure to Psychosis Risk
Adolescent cannabis exposure psychosis risk is a critical concern supported by large-scale research. This study highlights the increased vulnerability to psychotic disorders linked to cannabis use during adolescence. Understanding this risk is vital for…
Rapid Dose Therapeutics Advances Cannabinoid Studies for QuickStrip Drug Delivery Platform
Oral thin film cannabinoid delivery is an emerging technology addressing challenges in cannabis medicine. This delivery method offers faster onset and more precise dosing compared to traditional edibles. QuickStrip's platform exemplifies innovation in…
US Cannabis Rescheduling: A Victory or a Federal Trap?
Cannabis federal policy impacts patient access significantly as rescheduling shifts cannabis regulation. This change risks disrupting state medical cannabis programs. Understanding these federal policy impacts is essential for clinicians and patients.
